Phase III - International Pharmaceutical Industry

HOME
CURRENT
FEATURES
EDITORIAL
ARCHIVES
ARCHIVED
ISSUES
EVENTS
COMPANY
PROFILES
A-D

E-M

N-S

T-Z
SPONSORED
ARTICLES
NEWS
EBOOKS

SCHOTT Pharma
PODCAST
Generic selectors

Exact matches only

Search in title

Search in content

Post Type Selectors

Current Edition

News

Novartis’ Kymriah fails to hit primary survival endpoint in late-stage trial

The Phase III Belinda study investigating Kymriah (tisagenlecleucel) for treatment of non-Hodgkin lymphoma did not meet its primary endpoint of event-free survival c...

25 August 2021 News B-cell | Kymriah

Continue Reading →

News

FDA approves Keytruda plus Lenvima for advanced kidney cancer

The US Food and Drug Administration (FDA) has approved a combination of MSD’s anti-PD-1 therapy Keytruda (pembrolizumab) plus Eisai’s Lenvima (lenvatinib) for the fi...